What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Disease
His primary areas of investigation include Surgery, Internal medicine, Gastroenterology, Crohn's disease and Ulcerative colitis.
Michael A. Kamm regularly links together related areas like Clinical trial in his Surgery studies.
His Internal medicine study combines topics in areas such as Placebo and Placebo-controlled study.
His Gastroenterology course of study focuses on Endocrinology and Gastric emptying.
His Crohn's disease research is multidisciplinary, incorporating perspectives in Colonoscopy, Radiology, Fistula and Infliximab.
His studies deal with areas such as Incidence, Colitis, Inflammatory bowel disease, Primary sclerosing cholangitis and Colorectal cancer as well as Ulcerative colitis.
His most cited work include:
- Infliximab Maintenance Therapy for Fistulizing Crohn's Disease (1693 citations)
- Anal-sphincter disruption during vaginal delivery (1356 citations)
- Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis (954 citations)
What are the main themes of his work throughout his whole career to date?
Michael A. Kamm spends much of his time researching Internal medicine, Surgery, Gastroenterology, Crohn's disease and Inflammatory bowel disease.
His work on Ulcerative colitis, Constipation and Adverse effect as part of general Internal medicine study is frequently linked to In patient, bridging the gap between disciplines.
The concepts of his Constipation study are interwoven with issues in Pelvic floor, Defecation and Physical therapy.
In the field of Gastroenterology, his study on Irritable bowel syndrome overlaps with subjects such as MMX.
He combines subjects such as Colonoscopy, Adalimumab, Post operative and Infliximab with his study of Crohn's disease.
The study incorporates disciplines such as Gut flora, Immunology, Incidence, Quality of life and Prospective cohort study in addition to Inflammatory bowel disease.
He most often published in these fields:
- Internal medicine (50.00%)
- Surgery (36.01%)
- Gastroenterology (37.10%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (50.00%)
- Crohn's disease (30.78%)
- Inflammatory bowel disease (29.81%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Crohn's disease, Inflammatory bowel disease, Gastroenterology and Surgery.
His is doing research in Ulcerative colitis, Randomized controlled trial, Adverse effect, Irritable bowel syndrome and Colonoscopy, both of which are found in Internal medicine.
His studies in Crohn's disease integrate themes in fields like Microbiome, Post operative, Microbiology, Proteus and Risk factor.
His research in Inflammatory bowel disease intersects with topics in Odds ratio, Prospective cohort study, Quality of life and Immunology.
His Gastroenterology research integrates issues from Adalimumab, Feces, Crohn disease, Thiopurine methyltransferase and Dosing.
His Surgery research is multidisciplinary, relying on both Faecal calprotectin and Pharmacotherapy.
Between 2015 and 2021, his most popular works were:
- Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial (496 citations)
- Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. (163 citations)
- Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis. (97 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
His scientific interests lie mostly in Inflammatory bowel disease, Internal medicine, Gastroenterology, Crohn's disease and Ulcerative colitis.
His Inflammatory bowel disease research is multidisciplinary, incorporating elements of Microbiome, Gut flora, Epidemiology, Adverse effect and Meta-analysis.
His research integrates issues of Colonoscopy, Biopsy and Pharmacology in his study of Gastroenterology.
He interconnects Odds ratio, Faecal calprotectin, Hemolysin and Surgery in the investigation of issues within Crohn's disease.
In his work, Adipose tissue, Sarcopenia and Cohort study is strongly intertwined with Risk factor, which is a subfield of Surgery.
His work carried out in the field of Ulcerative colitis brings together such families of science as Placebo, Colitis, Placebo-controlled study and Bacteroides.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
